Zobrazeno 1 - 10
of 131
pro vyhledávání: '"Masatoshi Inden"'
Autor:
Sora Sakamoto, Yuichi Riku, Teiko Komori Nomura, Akio Kimura, Naoki Yamahara, Kazuki Ohuchi, Mari Yoshida, Yasushi Iwasaki, Takayoshi Shimohata, Masatoshi Inden, Ryo Honda
Publikováno v:
Translational Neurodegeneration, Vol 13, Iss 1, Pp 1-5 (2024)
Externí odkaz:
https://doaj.org/article/553156f79250496cbe86aea492066627
Autor:
Ayaka Fujimaki, Kazuki Ohuchi, Shinnosuke Takizawa, Takanori Murakami, Hisaka Kurita, Isao Hozumi, Xiaopeng Wen, Yoshihisa Kitamura, Zhiliang Wu, Yoichi Maekawa, Masatoshi Inden
Publikováno v:
Scientific Reports, Vol 13, Iss 1, Pp 1-10 (2023)
Abstract Parkinson’s disease (PD) is a neurodegenerative disorder characterized by the loss of dopaminergic neurons in the substantia nigra. The pathological hallmark of PD is the appearance of intraneuronal cytoplasmic α-synuclein (α-Syn) aggreg
Externí odkaz:
https://doaj.org/article/23e27bfe83714e1d87896050c05584de
Publikováno v:
Journal of Pharmacological Sciences, Vol 148, Iss 1, Pp 152-155 (2022)
Type-III sodium-dependent phosphate transporters 1 and 2 (PiT 1 and PiT 2, respectively) are proteins encoded by SLC20A1 and SLC20A2, respectively. The ubiquitous distribution of SLC20A1 and SLC20A2 mRNAs in mammalian tissues supports the housekeepin
Externí odkaz:
https://doaj.org/article/8fd1865223504c0eb8f9c45f91c2edc5
Publikováno v:
Scientific Reports, Vol 10, Iss 1, Pp 1-12 (2020)
Abstract Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease characterized by the selective and progressive loss of motor neurons. Although many drugs have entered clinical trials, few have shown effectiveness in the treatment of
Externí odkaz:
https://doaj.org/article/e48cab865084418f8bfa5de678b709d1
Autor:
Masanori Hijioka, Kanori Kitamura, Daijiro Yanagisawa, Kaneyasu Nishimura, Kazuyuki Takata, Masatoshi Inden, Yoshihisa Kitamura
Publikováno v:
Journal of Pharmacological Sciences, Vol 144, Iss 3, Pp 183-187 (2020)
Oxidative stress is associated with the progression of the neurodegenerative diseases Parkinson's disease (PD) and cerebral ischemia. Recently, 5-aminolevulinic acid (5-ALA), an intermediate in the porphyrin synthesis pathway, was reported to exert a
Externí odkaz:
https://doaj.org/article/6f342e388074485b8a5d8c48427bd00c
Publikováno v:
Frontiers in Pharmacology, Vol 13 (2022)
Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disorder, characterized by the loss of upper and lower motor neurons, for which an effective treatment has yet to be developed. Previous reports have shown that excessive oxidative stress, re
Externí odkaz:
https://doaj.org/article/d80a99cb15f5400fb902efba313f7e3c
Autor:
Ryogo Umetsu, Mizuki Tanaka, Yoko Nakayama, Yamato Kato, Natsumi Ueda, Yuri Nishibata, Shiori Hasegawa, Kiyoka Matsumoto, Noriaki Takeyama, Kazuhiro Iguchi, Hiroyuki Tanaka, Eiichi Hinoi, Naoki Inagaki, Masatoshi Inden, Yoshinori Muto, Mitsuhiro Nakamura
Publikováno v:
Frontiers in Pharmacology, Vol 12 (2021)
Montelukast is a selective leukotriene receptor antagonist that is widely used to treat bronchial asthma and nasal allergy. To clarify the association between montelukast and neuropsychiatric adverse events (AEs), we evaluated case reports recorded b
Externí odkaz:
https://doaj.org/article/d1880c35162249e8b8c3548b327cd68e
Publikováno v:
Frontiers in Neuroscience, Vol 14 (2020)
To evaluate the therapeutic potential of stem cells for neurodegenerative diseases, emphasis should be placed on clarifying the characteristics of the various types of stem cells. Among stem cells, dental pulp stem cells (DPSCs) are a cell population
Externí odkaz:
https://doaj.org/article/b63324d32d6b4086a78aec4a4624c663
Autor:
Masatoshi Inden, Ayaka Takagi, Hazuki Kitai, Taisei Ito, Hisaka Kurita, Ryo Honda, Yuji O. Kamatari, Sora Nozaki, Xiaopeng Wen, Masanori Hijioka, Yoshihisa Kitamura, Isao Hozumi
Publikováno v:
International Journal of Molecular Sciences, Vol 22, Iss 21, p 11484 (2021)
Aggregation of α-synuclein (α-Syn) is implicated in the pathogenesis of Parkinson’s disease (PD), dementia with Lewy bodies (DLB), and multiple system atrophy (MSA). Therefore, the removal of α-Syn aggregation could lead to the development of ma
Externí odkaz:
https://doaj.org/article/a7dc0a65bfb849738ef8075268babd97
Autor:
Shin-ichiro Sekine, Takayuki Kondo, Nagahisa Murakami, Keiko Imamura, Takako Enami, Ran Shibukawa, Kayoko Tsukita, Misato Funayama, Masatoshi Inden, Hisaka Kurita, Isao Hozumi, Haruhisa Inoue
Publikováno v:
Stem Cell Research, Vol 24, Iss C, Pp 40-43 (2017)
Idiopathic basal ganglia calcification (IBGC), also known as Fahr disease or primary familial brain calcifications (PFBC), is a rare neurodegenerative disorder characterized by calcium deposits in basal ganglia and other brain regions, causing neurop
Externí odkaz:
https://doaj.org/article/ca83311820a143458bf3559849bcf6a0